- Home
- / Singular Genomics
Singular Genomics
Stock Price
$13.6
2024-10-29
Market Capitalization
$33.9 M
2024-10-29
Revenue
$2.9 M
FY, 2023
Singular Genomics Summary
Company Summary
- Overview
- Singular Genomics Systems is a life science technology company that develops next-generation sequencing (NGS) and multi-omics technologies to build products for researchers and clinicians. It focuses on nucleotides, linkers, and fluorescent dyes synthesis.
- Type
- Public
- Status
- Active
- Founded
- 2016
- HQ
- San Diego, CA, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Eli Glezer, CSO & Founder
Jorge Velarde, Senior Vice President of Corporate Development & Strategy
Daralyn Durie, General Counsel
Operating MetricsView all
Facility Space Leased, sq. ft.
83.5K
FY, 2021
LocationsView all
1 location detected
San Diego, CA HQ
United States
3010 Science Park Rd
Singular Genomics Financials
Summary Financials
- Revenue (Q3, 2024)
- $406.0K
- Gross profit (Q3, 2024)
- ($301.0K)
- Net income (Q3, 2024)
- ($16.8M)
- Cash (Q3, 2024)
- $52.6M
- EBIT (Q3, 2024)
- ($18.1M)
- Enterprise value
- ($8.4M)